SU-E-T-227: Re-Evaluation of Dose Distribution and Margins for IMRT Prostate Plans

Medical Physics
W HeW Chen

Abstract

To evaluate the dose distribution on prostate and proximal seminal vesicles (SVs), rectum, and bladder when a certain geometry uncertainty is occurred during planning or delivery, and further determine the optimistic margin relation to different directions. Thirty prostate cancer patients with prostate specific antigen (PSA) less than 10 and Gleason Score between 2 and 6 have been selected and planned in EclipseTM 10.0 treatment planning system. PTV is expanded from GTV (prostate plus proximal SVs) with uniform 6 mm margin in all directions. All patients are head-first-supine and planned with seven beam IMRT technique. At least 95% of PTV is covered by full prescription. Rectum V65 is less than 17%, rectum V40 is less than 35%, bladder V65 is less than 25%, and bladder V40 is less than 50%. To simulate the deviation from planning error or setup uncertainty, the original isocenter of each plan has been shifted every 2mm from 0mm to 10mm in superior (S), inferior (I), right (R), left (L), anterior (A), and posterior (P) directions. The dose is then re-calculated with fixed jaw technique. The new plan parameters such as PTV coverage, both bladder and rectum V65 and V40 are analyzed. PTV full dose coverage is linearly decreasing wi...Continue Reading

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.